27.08
1.31%
+0.35
Chemours Company stock is currently priced at $27.08, with a 24-hour trading volume of 1.03M.
It has seen a +1.31% increased in the last 24 hours and a -2.80% declined in the past month.
The chart indicates a potential bullish trend, as the stock is above the $26.59 pivot point. If it approaches the $27.39 resistance level, significant changes may occur.
Previous Close:
$26.73
Open:
$26.76
24h Volume:
1.03M
Market Cap:
$4.03B
Revenue:
$6.03B
Net Income/Loss:
$-237.00M
P/E Ratio:
-13.47
EPS:
-2.01
Net Cash Flow:
$186.00M
1W Performance:
+2.69%
1M Performance:
-2.80%
6M Performance:
+12.41%
1Y Performance:
-6.36%
Chemours Company Stock (CC) Company Profile
Name
Chemours Company
Sector
Industry
Phone
302-773-1000
Address
1007 Market Street, Wilmington, DE
Chemours Company Stock (CC) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Dec-01-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
Jun-22-23 | Downgrade | BofA Securities | Buy → Neutral |
Jan-24-23 | Upgrade | UBS | Neutral → Buy |
Jan-11-23 | Upgrade | BofA Securities | Neutral → Buy |
Jan-10-23 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
Nov-01-22 | Initiated | Credit Suisse | Underperform |
Oct-13-22 | Initiated | Goldman | Neutral |
Oct-05-22 | Downgrade | Argus | Buy → Hold |
Jun-14-22 | Downgrade | BofA Securities | Buy → Neutral |
Jun-10-21 | Initiated | Wolfe Research | Outperform |
Jun-09-21 | Upgrade | Goldman | Neutral → Buy |
May-20-21 | Initiated | BofA Securities | Buy |
May-06-21 | Upgrade | Argus | Hold → Buy |
Jan-08-21 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
Dec-04-20 | Downgrade | Barclays | Overweight → Equal Weight |
Nov-30-20 | Initiated | Alembic Global Advisors | Overweight |
Mar-23-20 | Downgrade | Jefferies | Buy → Hold |
Feb-14-20 | Upgrade | CFRA | Buy → Strong Buy |
Nov-06-19 | Upgrade | CFRA | Hold → Buy |
Aug-20-19 | Upgrade | Susquehanna | Neutral → Positive |
Aug-09-19 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
Aug-06-19 | Downgrade | Argus | Buy → Hold |
Aug-05-19 | Downgrade | SunTrust | Buy → Hold |
Jul-12-19 | Downgrade | Citigroup | Buy → Neutral |
May-06-19 | Downgrade | JP Morgan | Overweight → Neutral |
Apr-15-19 | Upgrade | SunTrust | Hold → Buy |
Feb-19-19 | Downgrade | Susquehanna | Positive → Neutral |
Jan-08-19 | Initiated | HSBC Securities | Buy |
Jan-04-19 | Upgrade | Citigroup | Neutral → Buy |
Nov-02-18 | Downgrade | Citigroup | Buy → Neutral |
Jul-18-18 | Initiated | RBC Capital Mkts | Outperform |
Jan-30-18 | Initiated | Morgan Stanley | Equal-Weight |
Dec-06-17 | Downgrade | Goldman | Buy → Neutral |
Aug-07-17 | Upgrade | UBS | Sell → Neutral |
View All
Chemours Company Stock (CC) Latest News
Stepan Co. (SCL) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Zacks Investment Research
Analysts Estimate Chemours (CC) to Report a Decline in Earnings: What to Look Out for
Zacks Investment Research
Wall Street's Most Accurate Analysts' Views On 3 Materials Stocks Delivering High-Dividend Yields
Benzinga
Why Chemours Gets A Double Upgrade From This Analyst
Benzinga
Peeling Back The Layers: Exploring Chemours Through Analyst Insights
Benzinga
Chemours (CC) Recently Broke Out Above the 20-Day Moving Average
Zacks Investment Research
Chemours Company Stock (CC) Financials Data
Chemours Company (CC) Revenue 2024
CC reported a revenue (TTM) of $6.03 billion for the quarter ending December 31, 2023, a -11.29% decline year-over-year.
Chemours Company (CC) Net Income 2024
CC net income (TTM) was -$237.00 million for the quarter ending December 31, 2023, a -141.00% decrease year-over-year.
Chemours Company (CC) Cash Flow 2024
CC recorded a free cash flow (TTM) of $186.00 million for the quarter ending December 31, 2023, a -58.48% decrease year-over-year.
Chemours Company (CC) Earnings per Share 2024
CC earnings per share (TTM) was -$1.61 for the quarter ending December 31, 2023, a -144.35% decline year-over-year.
About Chemours Company
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Fluoroproducts, and Chemical Solutions. The Titanium Technologies segment manufactures and sells titanium dioxide under the Ti-Pure and BaiMax brands for various applications in architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride window profiles, laminate papers used for furniture and building materials, and coated papers and paperboards used for packaging. The Fluoroproducts segment provides fluoroproducts, including refrigerants, and industrial fluoropolymer resins and derivatives under the Teflon, Viton, Krytox, and Nafion brand names. The Chemical Solutions segment offers industrial and specialty chemicals for gold production, oil and gas, water treatment, electronics, and automotive industries. It also provides sodium cyanide through its mining solutions business; and performance chemicals and intermediates, such as methylamines, glycolic acid, and Vazo free radical initiators. The Chemours Company was founded in 2014 and is headquartered in Wilmington, Delaware.
Cap:
|
Volume (24h):